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While the final metrics were published in a previous article (J Am Coll Cardiol. 2017 Feb 
7;69(5):541-555. doi: 10.1016/j.jacc.2016.11.043), this article dives in detail to explain 
the development and early stages of the Kawasaki disease ambulatory metrics. For 
pediatricians considering developing metrics related to the care of children in the 
ambulatory setting, this article explains in details the organization of a team, selection of 
metrics and the different development milestones. This paper is not under consideration 
for publication elsewhere, and all authors have read and approved the manuscript. This 
submission is with the full knowledge and approval of the listed coauthors.
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Abstract
The Adult Congenital and Pediatric Cardiology Section (ACPC) of the American College 
of Cardiology sought to develop quality indicators/metrics for ambulatory pediatric 
cardiology practice. The objective of this study was to report the creation of metrics for 
patients with Kawasaki Disease (KD). Over a period of five months, 12 pediatric 
cardiologists developed 24 quality metrics based on the most relevant statements, 
guidelines, and research studies pertaining to KD. Of the 24 metrics, the eight metrics 
deemed the most important, feasible and valid were sent on to the ACPC for 
consideration. Seven of the eight metrics were approved using the RAND method by an 
expert panel. All seven metrics approved by ACPC council were accepted by ACPC 
membership after an “open comments” process. They have been disseminated to the 
pediatric cardiology community for implementation by the ACPC Quality Network™.
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INTRODUCTION
Kawasaki disease (KD) is the leading acquired heart disease in developed 
countries.1 Without timely diagnosis and treatment, 25% of these children have 
coronary artery involvement. In 2004, the American Heart Association (AHA) and 
American Academy of Pediatrics jointly published a scientific statement on the 
diagnosis and management of KD,1 which included recommendations for treatment in 
the acute phase and its long term management. The statement was revised in 2017.1 
Such statements are essential tools for clinical practice; they collect and analyze all 
published information, and recommend management strategies to practicing physicians 
to guide their care. They do not, however, evaluate compliance with recommendations 
or the quality of the care given by practitioners to identify areas of assessment or 
management that can be improved. Scientific statements and guidelines can be used to 
define benchmarks for care. Quality metrics derived from guidelines can be applied to 
record review to assess and promote quality of care. In this manner, metrics highlight a 
community’s adherence to current best practices and promote quality improvement. 
In 2012, the Adult Congenital and Pediatric Cardiology Section (ACPC) of the 
American College of Cardiology (ACC) sought to create quality metrics for ambulatory 
pediatric cardiology care. Within this initiative, KD was chosen as a specific area of 
practice for metric development, particularly because of the existence of the 2004 AHA 
Scientific Statement on Kawasaki disease noted above. Metric development was 
focused on ambulatory care provided to patients treated for KD by pediatric 
cardiologists following hospital discharge. This project was one of five that were 
undertaken under the auspices of ACPC and that recently were published as a group.3 
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This manuscript presents, in greater detail, the development of the KD metrics from 
their inception to implementation.
METHODS:
Work Process
The Kawasaki Disease metric development team consisted of 12 pediatric 
cardiologists from North America. Monthly conference calls and e-mail communications 
were used to survey team members for potential areas of focus for outpatient KD 
metrics. Key areas of focus included all disease phases of KD: the diagnosis of KD, its 
acute management (through 6-8 weeks follow up), and the long-term management of 
patients with coronary arterial involvement. Team members were then divided into 
subgroups of 2-3 cardiologists who wrote metrics related to a specific area of focus. 
Each subgroup evaluated the existing literature to help formalize the metric. The 
presentation of the quality metric included a description of the metric, the numerator, the 
denominator, the period of assessment, the data source, the rationale, the method of 
reporting, and challenges to its implementation.
Metrics were initially created, modified, and circulated to the full committee for 
review. Metrics that included inpatient care or data collection, or that were deemed too 
difficult to implement, were discarded. An Oversight Subcommittee (David Teitel, 
Michael Portman, and Jane Newburger) refined the eight final metrics (Table 1), and 
converted them into a uniform structure for submission to the ACPC expert panel. Using 
the RAND process to evaluate validity and feasibility,4 described in detail in an earlier 
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manuscript,3 the Expert Panel sent seven of the eight metrics to the Steering Committee 
for consideration. In turn, the Steering Committee sent those seven metrics out to all 
ACPC members for feedback. The comments received were then reviewed by the 
Steering Committee and the metrics were accepted, modified (if minor concerns) or 
rejected. Of the seven metrics sent by the Expert Panel to the Steering Committee, all 
were approved during the open comments process and finally approved by the ACPC 
council.
Utilization of Existing Guidelines
KD was unique among the pediatric ambulatory quality metric projects in having 
an AHA Scientific Statement to provide guidance for ambulatory care.1, 2 The 2004 AHA 
Statement were published before our metric project was undertaken and served as the 
basis for many of the developed metrics. For each metric, a citation from the 2004 AHA 
Statement was referenced in the clinical recommendation section of the metric. In 
addition, it was used to design the risk stratification that we incorporated into each 
metric, as noted above. Table 5 in the AHA Scientific Statement presents much of the 
information that was used in the creation of several of the metrics.1
Recognizing that the 2004 Scientific Statement would be updated, we sought to 
choose metrics that were based upon the strongest levels of evidence in contemporary 
literature that would be considered in the new scientific statement. We also made the 
criteria for risk stratification based upon aneurysms as non-specific as possible (small, 
medium, etc., rather than specific dimensions), allowing for new variables such as z-
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scores to be incorporated into the metric, and did not specify the type of stress testing 
technique to allow for emerging modalities..
In addition to the Scientific Statement, other guidelines were used in metric 
construction and justification. “Guidelines for Diagnosis and Management of 
Cardiovascular Sequelae in Kawasaki Disease,” developed by a joint working group of 
the Japanese Circulation Society,5 also informed many of our metrics, particularly those 
related to the long-term management of patients with coronary aneurysms. Since much 
of outpatient diagnostic activity relates to echocardiography, we referenced the 
guidelines developed by the American Society of Echocardiography for the performance 
of a pediatric echocardiogram.6 We referenced the 36th Bethesda Conference on 
Eligibility Recommendations for Competitive Athletes with Cardiovascular 
Abnormalities, which, in Task Force 2, discusses exercise limitations in patients with 
KD.7 These guidelines have also been updated recently, in a joint AHA and ACC 
Scientific Statement.8 Although we created one metric based on exercise limitations, it 
was not submitted. Lastly, because morbidity in KD is caused primarily by acute or 
chronic coronary artery disease, we referenced the NIH-commissioned “Expert Panel on 
Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and 
Adolescents”.9
Literature Reviewed
For each metric, we cited the specific statements within the various guidelines 
that justified adherence to the metric, as noted above. When the level of evidence was 
limited or there was no further corroborating data, we used other manuscripts, which 
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both pre-dated and post-dated the various guidelines, to form the rationale for our 
clinical recommendations. This was particularly necessary with regard to the use of 
echocardiography in following the disease process, and the categorization and 
treatment of coronary aneurysms, which is an evolving field. For example, Manlhiot 
described a classification system for coronary aneurysms based only on z-score,10 and 
Sugahara et al.11 demonstrated the value of warfarin in preventing myocardial infarction 
in patients with giant aneurysms. The variability and cost-effectiveness of 
echocardiography in children with KD were considered in studies by Scott et al.12 and 
Lowry et al.13, respectively.
Implementation of KD quality metrics
In early 2015, the ACC created a structure via which the quality metrics could be 
implemented. It is called ACPC Quality Network. Phase 1 (a pilot project of 3 sites) and 
Phase 2 (a “soft launch” with 13 sites) were undertaken in the second half of 2015 and 
the first half of 2016, respectively. The full launch was begun in the third quarter of 
2016, after the ACC informed academic pediatric cardiology programs and private 
pediatric cardiology practices of the initiative. Those groups which decided to participate 
received all of the approved metrics and their quarterly data has been submitted since 
that time. Each center was assigned a unique alphabetical letter and their data is both 
presented individually and reported as an average for the metric in each quarterly 
report. 
Page 9 of 25
http://mc.manuscriptcentral.com/clp
Clinical Pediatrics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
10
RESULTS
Key Decisions
When planning the development of the metrics, we chose to include all phases of 
the experience in the ambulatory pediatric cardiology practice, as well as each of the 
various risk classifications, focusing particularly on the high-risk patient with coronary 
aneurysms. We also sought to align the proportions of metrics relevant to each phase of 
illness with the corresponding relative time devoted to that illness phase in the 
outpatient cardiology office. Following our initial email conversations and phone 
conference, we defined eight potential metrics for diagnostic and acute management 
phase, and 12 for the late management phase, 10 of which focused on patients who 
had had aneurysms at some point during the disease. During later discussions, one 
early phase metric was added and one was split into two (one for low risk and one for 
higher risk patients), and two chronic phase metrics were added, leading to a total of 24 
metrics. 
In our creation of metrics for all phases of cardiac care for KD patients, we 
prioritized both feasibility (ease and reliability of data extraction from the medical record) 
and the importance of the metric to patient outcome. The study advisors were 
particularly helpful in considering feasibility, each having created quality metrics for 
adult congenital heart disease in the past.
Issues of data validity were particularly challenging for a variety of reasons. The 
AHA Scientific Statement that we were referencing at the outset of this project was 
published more than a decade ago. Not only has the treatment of KD evolved, but 
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diagnostic tests have advanced; for example, stress evaluations are being done using a 
variety of new techniques, and advanced non-invasive imaging modalities (CTA, cMRA) 
have replaced cardiac catheterization in many centers. In addition, the definition of large 
and giant aneurysms was in flux at the time, and recent literature supports the use of z-
score criteria to determine when anticoagulation should be added to anti-platelet 
therapy to prevent coronary thrombosis. Indeed, this approach has been adopted in the 
new Scientific Statement.3 Therefore, we focused on constructing quality metrics that 
were specific to important areas of evaluation and care throughout the course of KD in 
low and high risk patients while keeping the methodologies of risk stratification, 
investigation and care non-specific enough to allow the metrics to remain relevant as 
new statements and guidelines are published. We believe that this approach 
comprehensively interrogates the important components in the quality of outpatient KD 
care while being sufficiently general and evidence-based to maintain validity in face of 
new original research or updated guidelines. 
Final Recommendations
The original metrics were discussed and revised in multiple venues, including 
conference calls with the entire team, individual email discussions, phone conversations 
of our oversight group, and email and phone conversations with the Steering Committee 
and Advisors. Our team finalized eight metrics and sent them through the Steering 
Committee to the Expert Panel for consideration (Table 1). Rating each metric on 
validity and feasibility using the RAND modified Delphi Expert Panel process,4 the Panel 
approved seven of the eight.
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In consideration of the eighth metric, the Expert Panel determined that data 
acquisition around discussion of preventative care in KD patients with aneurysms was 
problematic. It was unclear to the panel how one could reliably extract evidence from 
the chart that an appropriate discussion had been undertaken for many of the variables. 
Not only was the feasibility of data acquisition uncertain, but the validity of the measure 
was questioned. Both the validity and feasibility scores for this metric were lower than 
for all of the others, and the range of scores across the experts was much wider, 
indicating lack of consensus. Thus, this metric was not approved for further 
consideration.
The Panel sent seven metrics back to the Steering Committee, without edits. The 
Steering Committee then sent the metrics out to the members of ACPC for 
consideration for the “open comments” process. There were no major concerns 
expressed during the open comments period, and all seven metrics were voted upon by 
the ACPC council for final approval. The final seven metrics met our goal, by 
encompassing the delivery of ambulatory care through all phases of KD and focusing on 
long-term outpatient care for patients with coronary aneurysms.
Implementation of KD Quality Metrics
As noted above, the ACC invited all US pediatric cardiac programs and practices 
known to them to participate in the implementation of the ambulatory pediatric 
cardiology quality metrics via ACPC Quality Network. Figure 1 portrays the data 
acquired from the beginning of the full launch through the second quarter of 2017, for 
ACPC Quality Metric 14, the proportion of patients without aneurysms who had at least 
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one echocardiogram within 3 weeks after being discharged from the hospital. The 
centers are able to review their own data across time periods, and compare their data 
with other centers and with the mean. With that information, they can determine where 
they need improvement and where they do not, develop strategies for improvement, 
and then determine the efficacy of those strategies.
DISCUSSION
We were able to develop seven KD ambulatory quality metrics by reviewing the 
existing literature that defined current best practices. The metrics were reviewed by 
experts in the field, who determined that the numerator and denominator of each metric 
could be ascertained, and that acquisition of data in the outpatient setting was both 
feasible and reliable. The metrics have since been disseminated by ACPC Quality 
Network, to afford pediatric cardiac programs the ability to evaluate their care, to 
compare that care to other programs, and to determine the efficacy of interventions 
aimed at improving their care. A Quality Network Collaborative National Quality 
Improvement project incorporating the KD metrics is under development and is 
expected to launch in early 2018.
Outpatient care of the KD patient is particularly suited to the use of quality 
metrics. In developing the outpatient KD metrics, we were mindful of several factors, 
including ease of data extraction from outpatient charts in diverse pediatric cardiology 
practice settings, the evolving nature of the care and evaluation of this patient 
population, the difficulty in defining a single standard with which to evaluate coronary 
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artery enlargement, and the existence of an outdated AHA Scientific Statement that was 
undergoing revision during our work. With increasing use of electronic medical records 
in the ambulatory setting, it should become easier to both extract the data needed to 
monitor compliance with these quality metrics and to use analytic tools to identify areas 
with opportunities for improvement. It is our hope that ambulatory quality metrics 
initiatives such as this one will encourage careful and comprehensive acquisition of data 
on the clinical care of KD patients, and will be used to compare that care to expected 
benchmarks. 
Ambulatory metrics will only succeed in improving care if practicing pediatric 
cardiologists embrace the initiative and are willing participants. Barriers to this initiative 
remain the motivation of caregivers and inadequate systems to extract and analyze data 
in a timely and effective manner. Outreach and educational programs by the ACC, with 
the ability to grant Maintenance of Certification credit for adherence, will be seminal in 
inspiring the use of outpatient metrics for care of KD patients in pediatric cardiology 
practices. Finally, these quality measures must be updated systematically as new 
research further improves care for the KD patient, and as new guidelines are 
developed.
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Figure Legends
Figure 1: Data acquired from participating centers since the full launch of the ACPC 
Quality Network project for Quality Metric 14, the proportion of KD patients without 
aneurysms who had at least one echocardiogram within 3 weeks of discharge from 
hospital (used with permission of the ACC).
Table 1: Candidate Quality Metrics for Kawasaki Disease submitted to Steering 
Committee
Of the eight metrics sent, seven (bold) were approved by the Expert Panel. All were 
approved by the Steering Committee.
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Table 1: Candidate Quality Metrics for Kawasaki Disease submitted to Steering 
Committee: Of the eight metrics sent, seven (bold) were approved by the Expert Panel. 
All were approved by the Steering Committee.
KAWASAKI DISEASE
Candidate Metric Numerator Denominator
Complete Echo Evaluation 
of Coronary Arteries in KD
number of patients who 
undergo an echocardiogram 
with recording of all 
necessary structures and 
measurements
all patients diagnosed with 
KD seen during timeframe
Aspirin Therapy in Acute 
and Subacute Phases of KD
patients discharged after 
initial admission for KD who 
are on aspirin at 3-5 mg/kg 
during the first 6 weeks of 
their course
patients discharged after 
initial admission for KD
Excluded Populations:
• Patients with G6PD 
deficiency
• Other contraindications 
to aspirin (allergy, recent 
varicella vaccination)
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49
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52
53
54
55
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57
58
59
60
For Peer Review
2
Appropriate Initial 
Outpatient Followup in KD 
Patients without Aneurysms
KD patients without 
aneurysms who have an 
echocardiogram performed 
within 3 weeks of hospital 
discharge
All KD patients found to 
have no aneurysms during 
hospital admission
Excluded Populations:
• Patients at higher risk – 
persistent or 
recrudescent fever, or 
remain hospitalized >five 
days, or readmitted
Appropriate Consideration 
and Evaluation of Fever in 
Acute and Subacute Phases 
of KD
KD patients who have 
assessment of fever post 
discharge at first cardiology 
outpatient visit
all KD patients seen in 
cardiology practice after 
hospital discharge
Excluded Population:
Patients whose first 
outpatient visit > 2 mos after 
discharge
Appropriate Care in Low 
Risk Patients (No Therapy or 
Restrictions) following 
Subacute Phase of KD
KD patients >8 weeks from 
disease onset with Risk 
Level I or II who are 
counseled that they do not 
need anti-platelet therapy or 
physical activity limitations
patients with KD >8 weeks 
from disease onset with 
Risk Level I or II
Excluded Populations:
• Patients who do not 
return for followup in this 
timeframe 
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3
Appropriate Stress 
Evaluation of KD Patients 
with Coronary Artery 
Aneurysms
KD patients >10 years with 
coronary aneurysms who 
have undergone exercise 
stress testing (myocardial 
perfusion or echo) within 30 
months of the current visit 
for small aneurysms or 
within 18 months for giant 
aneurysms
KD patients with current 
evidence of coronary 
aneurysms
Excluded Populations:
• Patients unable or 
decline to exercise
Appropriate Counseling re 
Myocardial Infarction in KD 
Patients with Giant 
Coronary Artery Aneurysms
KD patients with giant 
coronary aneurysms who 
have documentation of 
counseling regarding 
myocardial infarction within 
past 3 years
KD patients with history of 
giant coronary artery 
aneurysms
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4
Appropriate Discussion of 
Preventative Care in KD 
Patients with Aneurysms
KD patients >2 years of age 
with aneurysms and more than 
1 year post onset of KD who 
have documentation of ≥3 of 
the following 
measures/counseling:
1. Blood pressure
2. Lipid profile
3. Weight
4. BMI
5. Fasting glucose, 
hemoglobin A1C or fasting 
insulin
6. Family history of 
atherosclerotic heart 
disease
7. Avoidance of smoking
8. Avoidance of obesity
9. Exercise recommendations
10.Heart-healthy diet
11.Reproductive counseling
KD patients >2 years of age 
and more than one year post 
onset of KD who, at the time of 
evaluation, have coronary 
aneurysms
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Figure 1: Data acquired from participating centers since the full launch of the ACPC Quality Network project 
for Quality Metric 14, the proportion of KD patients without aneurysms who had at least one echocardiogram 
within 3 weeks of discharge from hospital (used with permission of the ACC). 
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